PHI-101 | m-entrepreneurship.com

Product Name :
PHI-101

Search keywords :
PHI-101

drugId :
null

Target Vo:
Checkpoint kinase 2

Target Vo Short Name :
Checkpoint kinase 2

Moa_Name:
Checkpoint kinase 2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pharos iBio Co Ltd

Active Company_Name :
Pharos iBio Co Ltd

Active Indication_Name:
Peritoneal Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HtrA2 (YP6097) Mouse mAb web
PRMT1 (Y10P72) Mouse mAb Technical Information
HDAC1 Antibody: HDAC1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to HDAC1. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts